AEGiS-AP: Panel: Spermicide Effects Iffy Associated PressImportant note: Information in this article was accurate in 1996. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu




DonateNow



Panel: Spermicide Effects Iffy

The Associated Press - Friday, 22 November 1996.


GAITHERSBURG, Md. (AP) -- Spermicides clearly work better than no contraceptive at all, but there's no way to say how effective they are or whether women should opt for a gel, foam, suppository or film, a scientific panel concluded Friday.

The advisers to the Food and Drug Administration heard disturbing evidence Friday that women who rely on spermicides as their sole contraceptive have anywhere from a 9 percent to a 57 percent chance of getting pregnant within a year.

And they appear to work best when used just 30 minutes before intercourse, said Dr. James Trussell of Princeton University.

But nobody knows for sure how well spermicides work, and which competitors work best, because the only studies ever performed were flawed. The manufacturers never proved how well their products work because they hit the market in 1950, before the FDA required such proof.

The National Institutes of Health is about to start a study comparing one brand of each type of spermicide sold to see how effective they are.

But the results won't be available for at least four years, so the FDA is debating what to tell consumers in the meantime and if that study will be enough.

The FDA may soon change spermicide labels at least to rank the products as less effective than other contraceptives, Dr. Lisa Rarick, the agency's reproductive health chief, said Friday.

Spermicides also should bear a warning that they may cause vaginal irritation, a condition one study suggests might increase a woman's chances of catching the AIDS virus, the scientific panel told the FDA.

However, the same panel on Wednesday agreed that spermicides can help protect women against two other sexually transmitted diseases, gonorrhea and chlamydia.


961122
AP961110


Copyright © 1996 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, Pacific Life Foundation, and donations from users like you.

Always watch for outdated information. This article first appeared in 1996. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1996. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .